239 related articles for article (PubMed ID: 23867758)
1. Development of Leptospira in vitro potency assays: EU/industry experience and perspectives.
Klaasen HL; van der Veen M; Molkenboer MJ; Bruderer U
Biologicals; 2013 Sep; 41(5):315-22. PubMed ID: 23867758
[TBL] [Abstract][Full Text] [Related]
2. Development of in vitro assays for measuring the relative potency of leptospiral bacterins containing serogroups canicola, grippotyphosa, icterohaemorrhagiae, and pomona.
Ruby KW; Srinivas GB
Biologicals; 2013 Sep; 41(5):308-14. PubMed ID: 23870804
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of a serological potency test for the release of Leptospira vaccines--requirements in the European Union.
Balks E; Gyra H; Kobe B; Cussler K; Werner E
Biologicals; 2013 Sep; 41(5):325-9. PubMed ID: 23911253
[TBL] [Abstract][Full Text] [Related]
4. Product-specific validation of a serological potency test for release of Leptospira vaccines in the European Union.
Stirling C; Novokova V
Biologicals; 2013 Sep; 41(5):330-1. PubMed ID: 23849308
[TBL] [Abstract][Full Text] [Related]
5. Expansion of the in vitro assay for Leptospira potency testing to other serovars: case study with Leptospira Hardjo.
Alt DP; Wilson-Welder J
Biologicals; 2013 Sep; 41(5):323-4. PubMed ID: 23838569
[TBL] [Abstract][Full Text] [Related]
6. European regulatory framework and practices for veterinary Leptospira vaccine potency testing.
Bruckner L
Biologicals; 2013 Sep; 41(5):303-4. PubMed ID: 23886926
[TBL] [Abstract][Full Text] [Related]
7. [Immunogenicity and protective capacity of leptospiral whole-cell monovalent serogroup Ballum vaccines in hamsters].
González A; Rodríguez Y; Batista N; Valdés Y; Núñez JF; Mirabal M; González M
Rev Argent Microbiol; 2005; 37(4):169-75. PubMed ID: 16502635
[TBL] [Abstract][Full Text] [Related]
8. Re-evaluating the LD50 requirements in the codified potency testing of veterinary vaccines containing Leptospira (L.) serogroup Icterohaemorrhagiae and L. serogroup Canicola in the United States.
Walker A; Olsen R; Toth M; Srinivas G
Biologicals; 2018 Nov; 56():13-18. PubMed ID: 30126631
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of the vaccine potentiality of 2 strains from Leptospira interrogans serogroup Ballum].
Rodríguez AG; Jiménez YR; Santiesteban NB; Abreu YV; Osenes JF; González MG
Rev Cubana Med Trop; 2005; 57(1):63-4. PubMed ID: 17966485
[TBL] [Abstract][Full Text] [Related]
10. USDA regulatory guidelines and practices for veterinary Leptospira vaccine potency testing.
Srinivas GB; Walker A; Rippke B
Biologicals; 2013 Sep; 41(5):298-302. PubMed ID: 23838570
[TBL] [Abstract][Full Text] [Related]
11. Development of antibody ELISA specific of Leptospira interrogans serovar Grippotyphosa, Canicola, and Icterohaemorrhagiae to monitor vaccine immunogenicity.
Cariou C; Herbet G; Ripart P; Martin-Cagnon N; Bouvet J; Schneider M; Guiot AL; Cupillard L
Vet Immunol Immunopathol; 2020 Jan; 219():109960. PubMed ID: 31760236
[TBL] [Abstract][Full Text] [Related]
12. Duration of immunity in dogs vaccinated against leptospirosis with a bivalent inactivated vaccine.
Klaasen HL; Molkenboer MJ; Vrijenhoek MP; Kaashoek MJ
Vet Microbiol; 2003 Aug; 95(1-2):121-32. PubMed ID: 12860082
[TBL] [Abstract][Full Text] [Related]
13. A canine vaccine against Leptospira serovars Icterohaemorrhagiae, Canicola and Grippotyphosa provides cross protection against Leptospira serovar Copenhageni.
Bouvet J; Lemaitre L; Cariou C; Scotto M; Blain C; Oberli F; Cupillard L; Guigal PM
Vet Immunol Immunopathol; 2020 Jan; 219():109985. PubMed ID: 31759261
[TBL] [Abstract][Full Text] [Related]
14. The serological response of working farm dogs to a vaccine containing Leptospira interrogans serovars Copenhageni and Pomona, and L. borgpetersenii serovar Hardjo.
Cave NJ; Harland AL; Allott SK
N Z Vet J; 2014 Mar; 62(2):87-90. PubMed ID: 24228620
[TBL] [Abstract][Full Text] [Related]
15. Opportunities and strategies to further reduce animal use for Leptospira vaccine potency testing.
Walker A; Srinivas GB
Biologicals; 2013 Sep; 41(5):332-7. PubMed ID: 23891496
[TBL] [Abstract][Full Text] [Related]
16. A new tetravalent canine leptospirosis vaccine provides at least 12 months immunity against infection.
Klaasen HL; van der Veen M; Sutton D; Molkenboer MJ
Vet Immunol Immunopathol; 2014 Mar; 158(1-2):26-9. PubMed ID: 24054091
[TBL] [Abstract][Full Text] [Related]
17. Report on the international workshop on alternative methods for Leptospira vaccine potency testing: state of the science and the way forward.
Stokes W; Srinivas G; McFarland R; Kulpa-Eddy J; Casey W; Walker A; Draayer H; Sebring R; Brown K; Balks E; Stirling C; Klaasen E; Hill R; Rippke B; Ruby K; Alt D; Mukhopadhyay S; Kojima H; Johnson N; Rinckel L; Doelling V; Jones B
Biologicals; 2013 Sep; 41(5):279-94. PubMed ID: 23890729
[TBL] [Abstract][Full Text] [Related]
18. Canine leptospirosis infections - clinical signs and outcome with different suspected Leptospira serogroups (42 cases).
Geisen V; Stengel C; Brem S; Müller W; Greene C; Hartmann K
J Small Anim Pract; 2007 Jun; 48(6):324-8. PubMed ID: 17490440
[TBL] [Abstract][Full Text] [Related]
19. Onset and duration of protective immunity against clinical disease and renal carriage in dogs provided by a bi-valent inactivated leptospirosis vaccine.
Minke JM; Bey R; Tronel JP; Latour S; Colombet G; Yvorel J; Cariou C; Guiot AL; Cozette V; Guigal PM
Vet Microbiol; 2009 May; 137(1-2):137-45. PubMed ID: 19179023
[TBL] [Abstract][Full Text] [Related]
20. Identification of immunodominant antigens in canine leptospirosis by Multi-Antigen Print ImmunoAssay (MAPIA).
Thomé S; Lessa-Aquino C; Ko AI; Lilenbaum W; Medeiros MA
BMC Vet Res; 2014 Dec; 10():288. PubMed ID: 25466383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
